Latest News about IDYA
Recent news which mentions IDYA
Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From Yesterday
September 13, 2022
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
September 12, 2022
From Benzinga
IDEAYA Shares Jump On Positive Interim Data From Eye Cancer Trial
September 12, 2022
Tickers
IDYA
From Benzinga
Why Ventyx Biosciences Is Trading Higher By 70%, Here Are 46 Stocks Moving In Monday's Mid-Day Session
September 12, 2022
From Benzinga
US Stock Futures Signal Higher Start On Wall Street; Crude Oil Rises
September 12, 2022
From Benzinga
Oracle, JPMorgan And 3 Stocks To Watch Heading Into Monday
September 12, 2022
From Benzinga
Looking Into IDEAYA Biosciences's Return On Capital Employed
September 09, 2022
Tickers
IDYA
From Benzinga
IDEAYA Achieves First Milestone In GSK Pact For Pol Theta Helicase Inhibitor Candidate
August 29, 2022
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 29, 2022
From Benzinga
AppLovin, Unity Software And Some Other Big Losers From Monday
August 16, 2022
From Benzinga
This Financial Services Stock Surged Around 116%; Here Are 86 Biggest Movers From Yesterday
August 16, 2022
From Benzinga
Gold Drops Over 1%; Viridian Therapeutics Shares Spike Higher
August 15, 2022
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
August 15, 2022
From Benzinga
Why IDEAYA Biosciences Shares Plunging Today
August 15, 2022
From Benzinga
Dow Surges Over 100 Points; Crude Oil Falls Sharply
August 15, 2022
From Benzinga
Why Viridian Therapeutics Is Trading Higher By Around 58%, Here Are 67 Stocks Moving In Monday's Mid-Day Session
August 15, 2022
From Benzinga
From Benzinga
From Benzinga
IDEAYA's Cancer Candidate Shows Early Tumor Modulation
July 27, 2022
From Benzinga
Ideaya Nominates Potential First-In-Class Pol Theta Helicase Inhibitor In Collaboration With GSK
June 28, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
March 16, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
March 15, 2022
From Benzinga
Ideaya Biosciences' IDE397 Shows Preliminary Tolerability In Early-Stage Solid Tumor Trial
March 15, 2022
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.